全文获取类型
收费全文 | 9524篇 |
免费 | 819篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 47篇 |
儿科学 | 249篇 |
妇产科学 | 141篇 |
基础医学 | 1180篇 |
口腔科学 | 378篇 |
临床医学 | 1059篇 |
内科学 | 2091篇 |
皮肤病学 | 104篇 |
神经病学 | 682篇 |
特种医学 | 303篇 |
外科学 | 1477篇 |
综合类 | 139篇 |
一般理论 | 7篇 |
预防医学 | 1032篇 |
眼科学 | 158篇 |
药学 | 749篇 |
中国医学 | 14篇 |
肿瘤学 | 542篇 |
出版年
2022年 | 75篇 |
2021年 | 186篇 |
2020年 | 96篇 |
2019年 | 175篇 |
2018年 | 225篇 |
2017年 | 162篇 |
2016年 | 173篇 |
2015年 | 183篇 |
2014年 | 284篇 |
2013年 | 397篇 |
2012年 | 587篇 |
2011年 | 587篇 |
2010年 | 329篇 |
2009年 | 299篇 |
2008年 | 484篇 |
2007年 | 510篇 |
2006年 | 501篇 |
2005年 | 494篇 |
2004年 | 487篇 |
2003年 | 386篇 |
2002年 | 443篇 |
2001年 | 185篇 |
2000年 | 175篇 |
1999年 | 201篇 |
1998年 | 83篇 |
1997年 | 102篇 |
1996年 | 80篇 |
1995年 | 78篇 |
1994年 | 75篇 |
1993年 | 60篇 |
1992年 | 133篇 |
1991年 | 131篇 |
1990年 | 113篇 |
1989年 | 124篇 |
1988年 | 114篇 |
1987年 | 103篇 |
1986年 | 102篇 |
1985年 | 115篇 |
1984年 | 92篇 |
1983年 | 99篇 |
1982年 | 88篇 |
1981年 | 76篇 |
1980年 | 50篇 |
1979年 | 85篇 |
1978年 | 55篇 |
1977年 | 60篇 |
1976年 | 62篇 |
1974年 | 55篇 |
1973年 | 42篇 |
1972年 | 47篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
91.
92.
Wilbert H M Heijne Angela L Slitt Peter J van Bladeren John P Groten Curtis D Klaassen Rob H Stierum Ben van Ommen 《Toxicological sciences》2004,79(2):411-422
Rats were exposed to three levels of bromobenzene, sampled at 6, 24, and 48 h, and liver gene expression profiles were determined to identify dose and time-related changes. Expression of many genes changed transiently, and dependent on the dose. Few changes were identified after 6 h, but many genes were differentially expressed after 24 h, while after 48 h, only the high dose elicited large effects. Differentially expressed genes were involved in drug metabolism (upregulated GSTs, mEH, NQO1, Mrps, downregulated CYPs, sulfotransferases), oxidative stress (induced HO-1, peroxiredoxin, ferritin), GSH depletion (induced GCS-l, GSTA, GSTM) the acute phase response, and in processes like cholesterol, fatty acid and protein metabolism, and intracellular signaling. Trancriptional regulation via the electrophile and sterol response elements seemed to mediate part of the response to bromobenzene. Recovery of the liver was suggested in response to BB by the altered expression of genes involved in protein synthesis and cytoskeleton rearrangement. Furthermore, after 48 h, rats in the mid dose group showed no toxicity, and gene expression patterns resembled the normal situation. For certain genes (e.g., CYP4A, metallothioneins), intraday variation in expression levels was found, regardless of the treatment. Selected cDNA microarray measurements were confirmed using the specific and sensitive branched DNA signal amplification assay. 相似文献
93.
94.
The aim of this study was to determine the role of pregnane X receptor (PXR) in the induction of UDP-glucuronosyltransferases (UGTs) by pregnenolone-16 alpha-carbonitrile (PCN). Four- to six-month-old male wild-type and PXR-null mice received control or PCN-treated (1500 ppm) diet for 21 days. On day 22, livers were taken to prepare microsomes and total RNA to determine UGT activity and mRNA levels, respectively. In wild-type mice, PCN treatment significantly increased UGT activities toward bilirubin, 1-naphthol, chloramphenicol, thyroxine, and triiodothyronine. On control diet, the UGT activities toward the above substrates (except for 1-naphthol) in the PXR-null mice were significantly higher than those of wild-type mice. However, UGT activities in PXR-null mice were not increased by PCN. In agreement with the above findings, mRNA levels of mouse Ugt1a1 and Ugt1a9, which are involved in the glucuronidation of bilirubin and phenolic compounds, were increased about 100% in wild-type mice following PCN treatment, whereas the expression of Ugt1a2, 1a6, and 2b5 was not affected. In contrast, PCN treatment had no effect on the mRNA levels of these UGTs in PXR-null mice. Taken together, these results indicate that PCN treatment induces glucuronidation in mouse liver, and that PXR regulates constitutive and PCN-inducible expression of some UGTs. 相似文献
95.
Brian L Sprague Amy Trentham-Dietz Curtis J Hedman Jue Wang Jocelyn DC Hemming John M Hampton Diana SM Buist Erin J Aiello Bowles Gale S Sisney Elizabeth S Burnside 《Breast cancer research : BCR》2013,15(3):R45
Introduction
Humans are widely exposed to estrogenically active phthalates, parabens, and phenols, raising concerns about potential effects on breast tissue and breast cancer risk. We sought to determine the association of circulating serum levels of these chemicals (reflecting recent exposure) with mammographic breast density (a marker of breast cancer risk).Methods
We recruited postmenopausal women aged 55 to 70 years from mammography clinics in Madison, Wisconsin (N = 264). Subjects completed a questionnaire and provided a blood sample that was analyzed for mono-ethyl phthalate, mono-butyl phthalate, mono-benzyl phthalate, butyl paraben, propyl paraben, octylphenol, nonylphenol, and bisphenol A (BPA). Percentage breast density was measured from mammograms by using a computer-assisted thresholding method.Results
Serum BPA was positively associated with mammographic breast density after adjusting for age, body mass index, and other potentially confounding factors. Mean percentage density was 12.6% (95% confidence interval (CI), 11.4 to 14.0) among the 193 women with nondetectable BPA levels, 13.7% (95% CI, 10.7 to 17.1) among the 35 women with detectable levels below the median (<0.55 ng/ml), and 17.6% (95% CI, 14.1 to 21.5) among the 34 women with detectable levels above the median (>0.55 ng/ml; Ptrend = 0.01). Percentage breast density was also elevated (18.2%; 95% CI, 13.4 to 23.7) among the 18 women with serum mono-ethyl phthalate above the median detected level (>3.77 ng/ml) compared with women with nondetectable BPA levels (13.1%; 95% CI, 11.9 to 14.3; Ptrend = 0.07). No other chemicals demonstrated associations with percentage breast density.Conclusions
Postmenopausal women with high serum levels of BPA and mono-ethyl phthalate had elevated breast density. Further investigation of the impact of BPA and mono-ethyl phthalate on breast cancer risk by using repeated serum measurements or other markers of xenoestrogen exposure are needed. 相似文献96.
Xiaoxia Guo Bing Xu Shuchita Pandey Elisabeth Goessl James Brown Angel L. Armesilla John L. Darling Weiguang Wang 《Cancer letters》2010
Most of the gemcitabine (dFdC) resistant cell lines manifested high NFκB activity. The NFκB activity can be induced by dFdC and 5-FU exposure. The chemosensitizing effect of disulfiram (DS), an anti-alcoholism drug and NFκB inhibitor, and copper (Cu) on the chemoresistant cell lines was examined. The DS/Cu complex significantly enhanced the cytotoxicity of dFdC (resistant cells: 12.2–1085-fold) and completely reversed the dFdC resistance in the resitant cell lines. The dFdC-induced NFκB activity was markedly inhibited by DS/Cu complex. The data from this study indicated that DS may be used in clinic to improve the therapeutic effect of dFdC in breast and colon cancer patients. 相似文献
97.
Govindan RB Lowery CL Campbell JQ Best TH Murphy P Preissl HT Eswaran H 《American journal of obstetrics and gynecology》2007,196(6):572-7; discussion 572.e7
98.
Neurodevelopmental changes of fetal pain 总被引:1,自引:1,他引:0
Lowery CL Hardman MP Manning N Hall RW Anand KJ Clancy B 《Seminars in perinatology》2007,31(5):275-282
Pain in the developing fetus is controversial because of the difficulty in measuring and interpreting pain during gestation. It has received increased attention lately because of recently introduced legislation that would require consideration of fetal pain during intentional termination of pregnancy. During development, sensory fibers are abundant by 20 weeks; a functional spinal reflex is present by 19 weeks; connections to the thalamus are present by 20 weeks; and connections to subplate neurons are present by 17 weeks with intensive differentiation by 25 weeks. These cells are important developmentally, but decline as a result of natural apoptosis. Mature thalamocortical projections are not present until 29 to 30 weeks, which has led many to believe the fetus does not experience emotional "pain" until then. Pain requires both nociception and emotional reaction or interpretation. Nociception causes physiologic stress, which in turn causes increases in catecholamines, cortisol, and other stress hormones. Physiological stress is different from the emotional pain felt by the more mature fetus or infant, and this stress is mitigated by pain medication such as opiates. The plasticity of the developing brain makes it vulnerable to the stressors that cause long-term developmental changes, ultimately leading to adverse neurological outcomes. Whereas evidence for conscious pain perception is indirect, evidence for the subconscious incorporation of pain into neurological development and plasticity is incontrovertible. Scientific data, not religious or political conviction, should guide the desperately needed research in this field. In the meantime, it seems prudent to avoid pain during gestation. 相似文献
99.
C F Curtis L N Otoo 《Transactions of the Royal Society of Tropical Medicine and Hygiene》1986,80(6):889-892
In an organism with a life-cycle modelled on that of Plasmodium two separate resistance genes are assumed, each protecting against one of two unrelated drugs. The model was used to compare the rates of build-up of resistance in a population where the two drugs are used either as a mixture or in sequence. The model suggests that the use of a mixture would be advantageous if: both resistances are initially rare; there is recombination between the genes; a large proportion of the parasite population is unexposed to the drugs. 相似文献
100.
Katarzyna Klonowska Joannes M. Grevelink Krinio Giannikou Barbara A. Ogorek Zachary T. Herbert Aaron R. Thorner Thomas N. Darling Joel Moss David J. Kwiatkowski 《The Journal of clinical investigation》2022,132(10)
BackgroundTuberous sclerosis complex (TSC) is a neurogenetic syndrome due to loss-of-function mutations in TSC2 or TSC1, characterized by tumors at multiple body sites, including facial angiofibroma (FAF). Here, an ultrasensitive assessment of the extent and range of UV-induced mutations in TSC facial skin was performed.MethodsA multiplex high-sensitivity PCR assay (MHPA) was developed, enabling mutation detection at extremely low (<0.1%) variant allele frequencies (VAFs).ResultsMHPA assays were developed for both TSC2 and TP53, and applied to 81 samples, including 66 skin biopsies. UV-induced second-hit mutation causing inactivation of TSC2 was pervasive in TSC facial skin with an average of 4.8 mutations per 2-mm biopsy at median VAF 0.08%, generating more than 150,000 incipient facial tumors (subclinical “micro-FAFs”) in the average TSC subject. The MHPA analysis also led to the identification of a refined UV-related indel signature and a recurrent complex mutation pattern, consisting of both a single-nucleotide or dinucleotide variant and a 1- to 9-nucleotide deletion, in cis.ConclusionTSC facial skin can be viewed as harboring a patchwork of clonal fibroblast proliferations (micro-FAFs) with indolent growth, a small proportion of which develop into clinically observable FAF. Our observations also expand the spectrum of UV-related mutation signatures.FundingThis work was supported by the TSC Alliance; the Engles Family Fund for Research in TSC and LAM; and the NIH, National Heart, Lung, and Blood Institute (U01HL131022-04 and Intramural Research Program). 相似文献